Hikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Gap Up – Here’s What Happened

by · The Cerbat Gem

Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $19.9825, but opened at $20.64. Hikma Pharmaceuticals shares last traded at $20.64, with a volume of 431 shares traded.

Hikma Pharmaceuticals Stock Up 3.3%

The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24. The stock’s 50-day moving average price is $21.72 and its two-hundred day moving average price is $24.17.

Hikma Pharmaceuticals Company Profile

(Get Free Report)

Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.

Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.

Featured Stories